Cellectis (CLLS) Enterprise Value (2014 - 2026)

Cellectis' Enterprise Value history runs 13 years deep, the most recent figure standing at -$185.7 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 28.4% year-over-year to -$185.7 million; the TTM figure through Mar 2026 stood at -$185.7 million (up 28.4% YoY), while the FY2025 annual figure was -$208.7 million, up 19.84% from the prior year.
• Enterprise Value was -$185.7 million for Q1 2026 at Cellectis, up from -$208.7 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$88.9 million in Q2 2023 to a low of -$272.8 million in Q2 2024.
• Historically, Enterprise Value has averaged -$186.0 million across 5 years, with a median of -$198.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 56.93% in 2023, then tumbled 206.79% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$93.1 million in 2022, then plunged by 105.81% to -$191.7 million in 2023, then tumbled by 35.78% to -$260.3 million in 2024, then advanced by 19.84% to -$208.7 million in 2025, then climbed by 11.02% to -$185.7 million in 2026.
• The last three Enterprise Value figures came in at -$185.7 million (Q1 2026), -$208.7 million (Q4 2025), and -$192.2 million (Q3 2025), per Business Quant data.